Erhöhte Lipasewerte beim akut-auf-chronischen Leberversagen (ACLF) sind mit einer erhöhten Mortalität assoziiert
Gero Kramer(Memorial Sloan Kettering Cancer Center), T Reiberger(Christian Doppler Laboratory for Thermoelectricity), Natalia Dominik(National Hospital for Neurology and Neurosurgery), Philipp Schwabl(Austrian Academy of Sciences), M Trauner(Medical University of Vienna), M Mandorfer(Medical University of Vienna), L Hartl(Medical University of Vienna), M Jachs(Medical University of Vienna), M Hintersteininger(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Christian Sebesta(Donauspital), Lorenz Balcar(Medical University of Vienna), B Simbrunner(Medical University of Vienna), G Semmler(Medical University of Vienna), Paul Thöne(Medical University of Vienna)
Cited by 0
Related Papers
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130